EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa

Eda Karadogan iD, Ahmet Sertcelik, Gulcin Telli Dizman, Hanife Uzar, Gulsen Hazirolan, Banu Cakir, Gokhan Metan iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkae476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Eda Karadogan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Division of Epidemiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cephalosporins, Tazobactam, Pseudomonas Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To develop a scoring system to predict resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa strains isolated from respiratory specimens.

Methods

A case–control study was conducted to evaluate the risk factors associated with resistance to ceftolozane/tazobactam. Patients with P. aeruginosa were defined as cases if they had ceftolozane/tazobactam-resistant strains, whereas those with ceftolozane/tazobactam-susceptible strains were defined as test-negative controls. A predictive scoring system based on binary logistic regression coefficients was formulated to predict resistance to ceftolozane/tazobactam. The score’s performance was assessed using ROC curves and AUC. The sensitivity, specificity and predictive values of the score were determined on the basis of a cut-off point, using the Youden index.

Results

Ceftolozane/tazobactam resistance was detected in 18.4% of P. aeruginosa isolates from 473 patients. In multivariate analysis, a history of bronchoscopy [OR (95% CI) = 2.1 (1.1–4.3), P = 0.035], invasive mechanical ventilation [OR (95% CI) = 2.4 (1.2–4.5), P = 0.009], colistin/polymyxin B use [OR (95% CI) = 3.2 (1.8–5.7), P < 0.001] and fluoroquinolone use [OR (95% CI) = 2.3 (1.1–4.8), P = 0.024] in the preceding month prior to P. aeruginosa isolation were significantly associated with ceftolozane/tazobactam resistance. The AUC (95% CI) of the score was 0.734 (0.675–0.794), with a sensitivity of 69%, specificity of 71.8%, positive predictive value of 35.5% and negative predictive value of 91.1% at the cut-off point of 2, out of a range of 0–5.

Conclusions

In respiratory tract infections caused by P. aeruginosa, use of the proposed scoring system may reduce inappropriate use of ceftolozane/tazobactam in empirical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCephalosporinsTazobactamPseudomonas InfectionsAnti-Bacterial AgentsRespiratory Tract InfectionsDrug Resistance, BacterialHumansMaleFemaleMiddle AgedAgedCase-Control StudiesMicrobial Sensitivity TestsAdultROC CurveSensitivity and SpecificityRisk Factors

Substanzen

CephalosporinsTazobactamAnti-Bacterial Agentsceftolozane, tazobactam drug combinationceftolozane

Autor:innen und Institutionen

  • Department of Public Health, Division of Epidemiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Department of Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Eda Karadogan, Gokhan Metan

Zitieren

APA

Karadogan, E., Sertcelik, A., Dizman, G. T., Uzar, H., Hazirolan, G., Cakir, B., & Metan, G. (2025). A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae476

Vancouver

Karadogan E, Sertcelik A, Dizman GT, Uzar H, Hazirolan G, Cakir B, et al. A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae476

BibTeX
@article{Karadogan2025,
  author = {Karadogan, Eda and Sertcelik, Ahmet and Dizman, Gulcin Telli and Uzar, Hanife and Hazirolan, Gulsen and Cakir, Banu and Metan, Gokhan},
  title = {A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkae476}
}
Kostenlos starten →